What Is Humanin? Mitochondrial-Derived Peptide

Cover illustration: AI-generated editorial artwork. Conceptual only; not an exact molecular structure, actual laboratory result or evidence of clinical effects.

Humanin is a 24-amino-acid peptide with an unusual provenance: its coding sequence lies in mitochondrial DNA, inside the 16S rRNA gene. It was the first described member of what is now called the mitochondrial-derived peptide class.

For laboratory research use only. The research materials supplied by HealthyWelness are not approved medicines, foods or cosmetics and are not for human or veterinary use. This article summarises published research and is not medical advice.

Key points

Length: 24 amino acids.
Encoded by: an open reading frame within the mitochondrial 16S rRNA gene.
Class: mitochondrial-derived peptide; MOTS-c is another.
Reported theme: cytoprotection, particularly against apoptotic insults.
Measured in human plasma as an endogenous peptide, with reported age-related variation.

Why the coding location is the interesting part

The standard account of mitochondrial DNA is compact: 13 respiratory chain subunits, 2 ribosomal RNAs, 22 transfer RNAs, and essentially nothing else. That genome is treated as fully annotated and devoted to oxidative phosphorylation.

Humanin complicates that picture. Its open reading frame sits within the 16S rRNA gene — a sequence already assigned another function. A short peptide encoded inside a structural RNA gene is a genuine surprise, and it implies the mitochondrial genome may carry regulatory information that annotation missed.

The conceptual consequence is larger than the one peptide. If mitochondria encode peptides that act outside the organelle, then mitochondria are signalling organelles, not only power plants. The 2015 Cell Metabolism paper on MOTS-c established the second member of the class and is the usual companion reference for this idea. See what MOTS-c is and how it compares with NAD+ research.

Discovery, and what the name reflects

Humanin was identified in a screen for factors that protected neuronal cells from an insult used in Alzheimer disease research. The name was given in that context. Its mitochondrial coding origin emerged afterwards — the peptide was found by activity first, and the genetics explained later.

This ordering is worth bearing in mind when reading the field. The earliest papers describe a protective activity without the mitochondrial framing, so terminology differs across the literature’s history, much as it does for the growth hormone secretagogues.

What the reviews report

Review	Focus	Theme
Hazafa et al., 2021 (Life Sci)	Apoptosis-related disease models	Cytoprotective activity across several insult types
Rochette et al., 2020 (Arch Cardiovasc Dis)	Cardiovascular systems	Role in cardiovascular disorders
Zuccato et al., 2019 (Expert Opin Ther Targets)	Cancer and degenerative disease	Humanin considered as a target as well as an agent

The 2019 review raises a point the others do not, and it is the sharpest thing in this literature: humanin is discussed as a potential target in cancer, not only as a protective agent. The logic is uncomfortable but straightforward. A peptide that protects cells from apoptosis is protecting cells, and tumour cells evading apoptosis is a defining feature of cancer. Cytoprotection is therefore not unconditionally desirable — it depends entirely on which cells are protected.

Any summary presenting humanin purely as beneficial has dropped this. It is the kind of mechanistic double edge that the primary literature handles carefully and secondary material tends to flatten.

Receptors and the mechanistic gap

Humanin has been reported to act through more than one route, including a receptor complex at the cell surface and intracellular interactions with apoptotic machinery. The relative contribution of these routes is not settled, and the reviews differ in emphasis.

For study design, that means the mechanism should be treated as an open question. An experiment showing protection does not by itself identify the route, and attributing an effect to a specific receptor requires blocking that receptor in the same system.

Handling in the lab

Supplied lyophilized; store sealed at −20 °C, protected from light and moisture.
Reconstitute gently — diluent down the vial wall, then swirl. Do not vortex.
At 24 residues, this peptide is long enough to show conformational behaviour: solvent and buffer choice can affect activity, so match published conditions where possible.
Aliquot and keep working solutions at 2–8 °C. See storing reconstituted peptides.
Several humanin analogues exist in the literature with substitutions altering potency — confirm from the certificate which sequence a vial contains before comparing results with a published figure.
Concentration maths: peptide reconstitution calculator.

Our humanin research material is supplied for laboratory research use. Certificates are available for listed products — contact us for the latest report.

Open questions

How is a peptide encoded in mitochondrial DNA actually translated and exported?
Which receptor or receptors account for the extracellular effects?
How should cytoprotection be evaluated when the same mechanism could favour tumour cell survival?

Frequently asked questions

What is humanin?

Humanin is a 24-amino-acid peptide whose coding sequence lies within the mitochondrial 16S ribosomal RNA gene, in mitochondrial DNA rather than the nuclear genome. It was the first peptide of this kind to be described.

What is a mitochondrial-derived peptide?

A short peptide encoded by an open reading frame within mitochondrial DNA. Mitochondrial DNA was long considered to encode only respiratory chain subunits, two rRNAs and tRNAs, so the existence of additional coded peptides was unexpected. MOTS-c is another member of the class.

How was humanin discovered?

It was identified in a screen for factors protecting neuronal cells from a form of insult used in Alzheimer research. The name reflects that origin. The mitochondrial location of its coding sequence was established subsequently.

Is humanin the same as MOTS-c?

No. Both are mitochondrial-derived peptides but they are different peptides from different regions of mitochondrial DNA, with different reported activities. MOTS-c is associated with metabolic regulation; humanin with cytoprotection.

Is humanin studied in humans?

Humanin has been measured in human plasma and tissues as an endogenous peptide in observational research. No interventional human trial of administered humanin was identified in our search; the intervention literature is cell and animal based.

References

Hazafa A, et al. Humanin: A mitochondrial-derived peptide in the treatment of apoptosis-related diseases. Life Sci. 2021. PMID: 33130077 https://pubmed.ncbi.nlm.nih.gov/33130077/
Rochette L, et al. Role of humanin, a mitochondrial-derived peptide, in cardiovascular disorders. Arch Cardiovasc Dis. 2020. PMID: 32680738 https://pubmed.ncbi.nlm.nih.gov/32680738/
Zuccato CF, et al. Mitochondrial-derived peptide humanin as therapeutic target in cancer and degenerative diseases. Expert Opin Ther Targets. 2019. PMID: 30582721 https://pubmed.ncbi.nlm.nih.gov/30582721/
Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015. PMID: 25738459 https://pubmed.ncbi.nlm.nih.gov/25738459/